Regulatory bodies like the FDA in the United States have stringent rules against off-label marketing. Pharmaceutical companies found promoting their drugs for off-label uses can face severe penalties, including fines and legal actions. The FDA monitors drug promotions and can issue warning letters or take other enforcement actions against companies that violate these regulations.
